iPhone | iPad
Android
Huawei
She was unable to process the news about her daughter’s fingers being amputated due to a medical emergency
KT APPDOWNLOAD
Covid-19: India says homegrown mRNA vaccine safe in early trial
Photo: Reuters
Bangalore - Government authorities have approved further studies to test the vaccine's efficacy in a larger population
Indian pharmaceutical firm Gennova Biopharmaceuticals' Covid-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
Government authorities have also approved further studies to test the vaccine's efficacy in a larger population. Gennova plans to conduct a mid-stage study at about 10 to 15 sites and a late-stage trial at 22 to 27 sites in India.
The company's vaccine development, partly funded by the government, will utilise the clinical trial network under the biotechnology department of the Ministry of Science and Technology.
ALSO READ:
>> India: Covid third wave likely to peak in October, experts say
>> Covid vaccine: India's Covaxin 93.4% effective against severe infection
Gennova is also investing in scaling up its vaccine manufacturing capacity, the government statement added.
Its parent firm, Emcure Pharmaceuticals, filed draft papers with the market regulator for an initial public offering last week.
More news from
Kanat Al Thuraya, as the season is called, is expected to last till June 7
The National Centre of Meteorology has issued an advisory, forecasting heavy rains and unstable weather conditions in the country
Nadal's reward is a last-16 clash with the 30th-seeded Jiri Lehecka
Other focal points showcased the partnership between the DP World Tour and the Emirates Golf Federation
The American pays tribute to mentor and good friend Mickelson following the success Down Under
UAE claimed an emphatic 10-wicket victory over the Netherlands
The match was a complete contrast to the previous game at the venue when Punjab Kings chased down an IPL record of 262 on another hot day
